IR415

IR415是有效的抗HBV试剂(anti-HBVagent)，可通过阻断HBx的活性来抑制HBV复制。IR415选择性地与HBx相互作用(Kd=2nM)并阻断HBV介导的RNAi抑制，逆转HBx蛋白对Dicer核糖核酸内切酶活性的抑制作用。

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
5mg

￥875.00

700.00

- +
10mg

￥1525.00

1220.00

- +
25mg

￥3050.00

2440.00

- +
50mg

￥5175.00

4140.00

- +
100mg

￥9175.00

7340.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

Background

IR415 is a potent anti-HBV agent and inhibits HBV replication by blocking the HBx activity. IR415 selectively interacts with HBx (Kd=2 nM) and blocks HBV-mediated RNAi suppression, reverses the inhibitory effect of HBx protein on the activity of the dicer endoribonuclease[1]. HBx: hepatitis B virus X protein.

Hepatitis B virus X protein (HBx) as a suppressor of host defenses consisting of RNAi-based silencing of viral genes[1].IR415 (50-200 μM) has a dose-dependent inhibitory effect on HBx, with a minimal effective concentration of 50 μM in HepG2/GFP-shRNA line transfected with HBx[1].

[1]. Ghosh S, et al. An RNAi-based high-throughput screening assay to identify small molecule inhibitors of hepatitis B virus replication.J Biol Chem. 2017 Jul 28;292(30):12577-12588.